Vertaling van "countries to have access " (Nederlands → Frans) :

However, it is also important for the population of these countries to have access to medicines of the same quality as those on the European market.
However, it is also important for the population of these countries to have access to medicines of the same quality as those on the European market.

Moreover, whereas in certain countries such as the United States and Columbia, access to means like firearms constitutes a real problem, things are rather different in our country.
Par ailleurs, si dans certains pays comme les Etats-Unis ou la Colombie, l’accessibilité à des moyens comme les armes à feu pose un véritable problème, la réalité rencontrée chez nous est sensiblement différente.

Likewise, research carried out up to now has shown that there appears to be a definite connection in all countries, both industrial and developing countries, between alcohol consumption (notably in the Russian Federation and the Baltic states), free access to certain toxic substances (e.g. in China, India and Sri Lanka) and firearms (e.g. in El Salvador and the United States) on the one hand, and the rate of suicide on the other.
De même, la consommation d’alcool (notamment en Fédération de Russie et dans les Etats baltes) ainsi que le libre accès à certaines substances toxiques (en Chine, en Inde et au Sri Lanka, par exemple) et aux armes à feu (à El Salvador et aux Etats-Unis d’Amérique, entre autres) semblent, d’après les études réalisées jusqu’à présent, associés de façon certaine aux taux de suicide dans tous les pays, industrialisés ou en développement.

The seriousness of the situation, the differences in regulations from country to country, the difficulty of determining at the start of an incident whether it is a quality problem or a problem of pharmacovigilance, are factors which have to be taken into account.
The seriousness of the situation, the differences in regulations from country to country, the difficulty of determining at the start of an incident whether it is a quality problem or a problem of pharmacovigilance, are factors which have to be taken into account.

In concrete terms, this means that out of a hundred individuals who suffer from a mental disorder, 33 seek professional help, whereas only 27 really do receive treatment. […] The fact that between 6 and 8 out of 10 of those who suffer from a mental disorder do not receive treatment suggests that the access to mental health care is littered with stumbling blocks that have an inhibiting effect, such as the attitude towards mental health, the availability of medical care, financial considerations or the extent to which individuals think they need help”. ) (Bruffaerts et al., 2004) 14
Concrètement, cela signifie que parmi 100 personnes qui souffrent d’un trouble mental, 33 demandent une assistance professionnelle et seules 27 reçoivent effectivement un traitement.[…] Le fait que 6 à 8 personne sur 10 souffrant d’un trouble mental ne reçoivent pas de traitement indique que l’accès aux soins de santé mentale est parsemé d’embûches qui exercent un effet inhibiteur, comme l’attitude vis-à-vis de la santé mentale, l’accessibilité aux soins, des

The FAMHP and the BUM department in particular ensures that all parties have access to such information, so that medicines can be used rationally and safely.
The FAMHP and the BUM department in particular ensures that all parties have access to such information, so that medicines can be used rationally and safely.

Be that as it may, care should be taken that patients do not have free access to antidepressants.
En tout état de cause, il faut veiller à ce que l’accès aux antidépresseurs ne soit pas laissé à la discrétion des patients.

To promote the proper use of a medicine, all relevant parties need to have objective, appropriate, up-todate and readily accessible information.
To promote the proper use of a medicine, all relevant parties need to have objective, appropriate, up-todate and readily accessible information.

In many countries, exported batches have to be accompanied by proof that they were produced in accordance with the GMP conditions.
In many countries, exported batches have to be accompanied by proof that they were produced in accordance with the GMP conditions.

The Eastern European countries have the highest, Latin America the lowest rates.
Les pays d’Europe de l’Est connaissent le plus haut taux, tandis qu’en Amérique latine, on observe les plus bas taux.